Skip to main content
OpenTrials

Clinical trial condition

Clear Cell Renal Cell Carcinoma

Explore clinical trials studying Clear Cell Renal Cell Carcinoma. Study availability and eligibility vary by location and protocol.

111 public trials 28 recruiting studies
Refine in advanced search Browse all conditions

Clear Cell Renal Cell Carcinoma trial results

Active, Not Recruiting

Pazopanib Hydrochloride and Bevacizumab in Treating Patients With Previously Untreated Metastatic Kidney Cancer

NCT01684397

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations
  • The University of Kansas Cancer Center Westwood, Kansas, United States
  • Karamanos Cancer Institute Detroit, Michigan, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States
View Trial Details
Active, Not Recruiting

Study of Nivolumab in Combination With 177Lu-girentuximab for Kidney Cancer

NCT05239533

Conditions
Adenocarcinoma, Advanced Renal Cell Carcinoma, Carcinoma, +16 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Active, Not Recruiting

A Study of Subcutaneous Nivolumab Versus Intravenous Nivolumab in Participants With Previously Treated Clear Cell Renal Cell Carcinoma That is Advanced or Has Spread

NCT04810078

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Local Institution Chicago, Illinois, United States
  • Local Institution - 0025 Buffalo, New York, United States
  • Local Institution - 0088 West Reading, Pennsylvania, United States
  • Local Institution - 0095 Capital Federal, Buenos Aires, Argentina
View all 89 locations
View Trial Details
Active, Not Recruiting

A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies

NCT05199272

Conditions
Adenocarcinoma, Adnexal Diseases, Bronchial Neoplasms, +45 more
Locations
  • Stanford Cancer Institute Palo Alto, California, United States
  • Emory University Atlanta, Georgia, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • R.J.Zuckerberg Cancer Center Lake Success, New York, United States
View all 13 locations
View Trial Details
Active, Not Recruiting

A Phase 1, Dose-Escalation Trial of PT2385 Tablets In Patients With Advanced Clear Cell Renal Cell Carcinoma (MK-3795-001)

NCT02293980

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +18 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Yale School of Medicine New Haven, Connecticut, United States
  • University of Miami - Sylvester Comprehensive Cancer Center Miami, Florida, United States
View all 25 locations
View Trial Details

Related conditions